Orlistat for overweight subjects with nonalcoholic steatohepatitis.

Orlistat for overweight subjects with nonalcoholic steatohepatitis.

ग्रंथसूची विवरण
मुख्य लेखकों:	Dowman, J, Stocken, D, Tomlinson, J, Newsome, P
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2009

समान संसाधन

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
द्वारा: Dowman, J, और अन्य
प्रकाशित: (2011)

Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.
द्वारा: Dowman, J, और अन्य
प्रकाशित: (2014)

Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis
द्वारा: Armstrong, M, और अन्य
प्रकाशित: (2013)

Pathogenesis of non-alcoholic fatty liver disease.
द्वारा: Dowman, J, और अन्य
प्रकाशित: (2010)

The diagnosis of non-alcoholic fatty liver disease: authors' reply
द्वारा: Dowman, J, और अन्य
प्रकाशित: (2012)

Current therapeutic strategies in non-alcoholic fatty liver disease.
द्वारा: Dowman, J, और अन्य
प्रकाशित: (2011)

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
द्वारा: Armstrong, M, और अन्य
प्रकाशित: (2013)

Necroptosis in Nonalcoholic Steatohepatitis
द्वारा: Jérémie Gautheron, PhD, और अन्य
प्रकाशित: (2015-05-01)

The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs
द्वारा: D. H. Ipsen, और अन्य
प्रकाशित: (2021-02-01)

Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
द्वारा: Armstrong, M, और अन्य
प्रकाशित: (2013)

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
द्वारा: Armstrong, M, और अन्य
प्रकाशित: (2014)

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.
द्वारा: Armstrong, M, और अन्य
प्रकाशित: (2014)

Nonalcoholic Steatohepatitis: An Evolving Diagnosis
द्वारा: Brent A Neuschwander-Tetri
प्रकाशित: (2000-01-01)

Oligonucleotide therapies for nonalcoholic steatohepatitis
द्वारा: Sixu Li, और अन्य
प्रकाशित: (2024-06-01)

Challenges and opportunities in nonalcoholic steatohepatitis
द्वारा: Wang Xiaobo
प्रकाशित: (2022-08-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
द्वारा: Anca Smaranda Farmazon, और अन्य
प्रकाशित: (2018-09-01)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
द्वारा: Gopanandan Parthasarathy, और अन्य
प्रकाशित: (2020-04-01)

The metabolic basis of nonalcoholic steatohepatitis
द्वारा: Manu V. Chakravarthy, और अन्य
प्रकाशित: (2020-10-01)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
द्वारा: Mindy C.W. Lam, और अन्य
प्रकाशित: (2012-07-01)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
द्वारा: Armstrong, M, और अन्य
प्रकाशित: (2015)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
द्वारा: Sebastião M.B. Duarte, और अन्य
प्रकाशित: (2019-05-01)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
द्वारा: Mazen Noureddin, और अन्य
प्रकाशित: (2020-10-01)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
द्वारा: Helma P. Cotrim, और अन्य
प्रकाशित: (2016-05-01)

Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis
द्वारा: S.M. Touhidul Islam, और अन्य
प्रकाशित: (2020-09-01)

Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
द्वारा: S. Gitto, और अन्य
प्रकाशित: (2015-01-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
द्वारा: Melanie D Beaton
प्रकाशित: (2012-01-01)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
द्वारा: Magdalena Mazurek, और अन्य
प्रकाशित: (2023-02-01)

Nonalcoholic Steatohepatitis in Nondiabetic Obese Patients
द्वारा: Idilio Zamin, और अन्य
प्रकाशित: (2002-01-01)

Human Nonalcoholic Steatohepatitis on a Chip
द्वारा: May S. Freag, और अन्य
प्रकाशित: (2021-02-01)

Uncovered issues in the overview of nonalcoholic steatohepatitis
द्वारा: Chia-Chi Wang
प्रकाशित: (2011-12-01)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
द्वारा: Hui Xiang, और अन्य
प्रकाशित: (2022-02-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
द्वारा: Seonghwan Hwang, और अन्य
प्रकाशित: (2021-10-01)

The regulatory state of nonalcoholic steatohepatitis and metabolism
द्वारा: Stephanie O. Omokaro, और अन्य
प्रकाशित: (2020-10-01)

Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis
द्वारा: D.N. Amarapurkar, और अन्य
प्रकाशित: (2006-01-01)

Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients
द्वारा: Alfredo Halpern, और अन्य
प्रकाशित: (2010-01-01)

Comparison of Metformin and Orlistat in Anovulatory, Overweight and Obese Women with Polycystic Ovarian Syndrome
द्वारा: Uzma Gul, और अन्य
प्रकाशित: (2023-06-01)

Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey
द्वारा: Venancio Avancini Ferreira Alves, और अन्य
प्रकाशित: (2016-08-01)

The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis
द्वारा: Janine Dywicki, और अन्य
प्रकाशित: (2022-02-01)

Nonalcoholic steatohepatitis and biliary sludge in people with metabolic syndrome
द्वारा: V G Radchenko, और अन्य
प्रकाशित: (2016-09-01)

5-ALPHA-REDUCTASE-1 KNOCKOUT PROTECTS AGAINST HEPATOCARCINOGENESIS IN A MURINE MODEL OF NASH
द्वारा: Dowman, J, और अन्य
प्रकाशित: (2012)